Phong Phu Pharmaceutical Valuation
Is PPP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PPP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PPP (₫18000) is trading below our estimate of fair value (₫23024.83)
Significantly Below Fair Value: PPP is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PPP?
Key metric: As PPP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is PPP's PE Ratio? | |
|---|---|
| PE Ratio | 9x |
| Earnings | ₫17.51b |
| Market Cap | ₫158.40b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 5.2x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does PPP's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.3x | ||
SPM SPM | 8.1x | n/a | ₫154.2b |
MED Mediplantex National Pharmaceutical | 18.2x | n/a | ₫297.8b |
MKV Cai Lay Veterinary Pharmaceutical | 6.7x | n/a | ₫46.0b |
PMC Pharmedic Pharmaceutical Medicinal | 16.4x | n/a | ₫1.0t |
PPP Phong Phu Pharmaceutical | 9x | n/a | ₫158.4b |
Price-To-Earnings vs Peers: PPP is good value based on its Price-To-Earnings Ratio (9x) compared to the peer average (12.3x).
Price to Earnings Ratio vs Industry
How does PPP's PE Ratio compare vs other companies in the Asian Pharmaceuticals Industry?
| 13 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 13 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: PPP is good value based on its Price-To-Earnings Ratio (9x) compared to the Asian Pharmaceuticals industry average (24.7x).
Price to Earnings Ratio vs Fair Ratio
What is PPP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 9x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PPP's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.